首页> 外文期刊>Clinical nuclear medicine >Reinforcing the Ability of (TcO4)-Tc-99m Scintigraphy for Identifying Differentiated Thyroid Cancer by TSH Stimulation
【24h】

Reinforcing the Ability of (TcO4)-Tc-99m Scintigraphy for Identifying Differentiated Thyroid Cancer by TSH Stimulation

机译:通过TSH刺激增强(TcO4)-Tc-99m闪烁显像法鉴别分化型甲状腺癌的能力

获取原文
获取原文并翻译 | 示例
           

摘要

Although radioiodines are widely used to localize metastatic differentiated thyroid cancer (DTC), (TcO4)-Tc-99m also can be used because it is a substrate for the sodium-iodide symporter protein. The use of (TcO4)-Tc-99m has advantages over radioiodine, namely, easy availability, dispensability of iodine restriction, and early imaging time. However, its low sensitivity precludes its practical application. Scintigraphic detectability of DTC using sodium-iodide symporter substrates is related to the serum TSH levels. Here, I report a case with multiple metastatic lesions of DTC that were detected upon TSH-stimulated (TcO4)-Tc-99m scintigraphy, but not with non-TSH-stimulated scintigraphy using the same tracer.
机译:尽管放射性碘被广泛用于定位转移分化的甲状腺癌(DTC),但(TcO4)-Tc-99m也可以使用,因为它是碘化钠转运蛋白的底物。 (TcO4)-Tc-99m的使用优于放射性碘,即容易获得,碘限制剂的可分配性和早期成像时间。但是,由于灵敏度低,因此无法实用。使用碘化钠共转运蛋白底物对DTC的闪烁示踪可检测性与血清TSH水平有关。在这里,我报告一例在TSH刺激(​​TcO4)-Tc-99m闪烁显像仪上检测到DTC的多个转移性病变,但在非TSH刺激显像仪上使用同一示踪剂检测到的情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号